Detection and significance of heparin-platelet factor 4 antibodies

Seminars in Hematology

Volumn 42, Issue SUPPL. 3, 2005, Pages S9-

  Francis, John L ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; HIRULOG; LEPIRUDIN;

ANTIBODY DETECTION; BLEEDING; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DRUG INDICATION; DRUG SUBSTITUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

EID: 23644446318     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.05.013     Document Type: Conference Paper

References (26)

1. J.L. Francis A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex Semin Thromb Hemost 30 2004 359 368
2. T.E. Warkentin Clinical picture of HIT T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia (ed 3). 2004 Marcel Dekker New York, NY 53 106
3. D.H. Lee, T.E. Warkentin Frequency of heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia (ed 3). 2004 Marcel Dekker New York, NY 107 148
4. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
5. J. Amiral, D. Meyer Heparin-dependent antigens in heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia (ed 3). 2004 Marcel Dekker New York, NY 165 177
6. T.E. Warkentin, A. Greinacher Heparin-induced thrombocytopenia: recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 2004 311S 337S
7. T.E. Warkentin, A. Greinacher Laboratory testing for heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia (ed 3). 2004 Marcel Dekker New York, NY 271 311
8. J.G. Kelton, D. Sheridan, H. Brain Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia J Lab Clin Med 103 1984 606 612
9. D. Sheridan, C. Carter, J.G. Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
10. D.H. Hickerson, A.P. Bode Flow cytometry of platelets for clinical analysis Hematol Oncol Clin North Am 16 2002 421 454
11. D.H. Lee, T.E. Warkentin, G.A. Denomme A diagnostic test for heparin-induced thrombocytopenia Detection of platelet microparticles using flow cytometry Br J Haematol 95 1996 724 731
12. A. Tomer A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia Br J Haematol 98 1997 648 656
13. M. Vitale, P. Tazzari, F. Ricci Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia Cytometry 46 2001 290 295
14. A. Leo, S. Winteroll Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants Clin Diagn Lab Immunol 10 2003 731 740
15. O. Meyer, A. Salama, N. Pittet Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4) Lancet 354 1999 1525 1526
16. P.L. Tazzari, F. Ricci, M. Vitale Heparin-induced thrombocytopenia detection of antiheparin/PF4 antibodies by means of heparin/PF4-coated beads and flow cytometry Transfus Med 12 2002 193 198
17. L. Chilver-Stainer, B. Lämmle, L. Alberio Titre of Anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems Thromb Haemost 91 2004 276 282
18. L. Alberio, S. Kimmerle, A. Baumann Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia Am J Med 114 2003 528 536
19. T.E. Warkentin, A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann Thorac Surg 76 2003 2121 2131
20. A.V. Mattioli, L. Bonetti, S. Sternieri Heparin-induced thrombocytopenia in patients treated with unfractionated heparin Prevalence of thrombosis in a 1 year follow-up Ital Heart J 1 2000 39 42
21. R.T. Williams, L.V. Damaraju, M.A. Mascelli Anti-platelet factor 4/heparin antibodies an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes Circulation 107 2003 2307 2312
22. J.L. Francis, G.J. Palmer, R. Moroose Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann Thorac Surg 75 2003 17 22
23. T.F. Slaughter, E. Bennett-Guerrero, Z. Su Anti-heparin-PF antibodies detected prior to cardiac surgery identify patients at high risk for adverse perioperative outcomes Anesth Analg 93 2002 SCA28 (abstr)
24. R. Robson, H. White, P. Aylward Bivalirudin pharmacokinetics and pharmacodynamics Effect of renal function, dose, and gender Clin Pharmacol Ther 71 2002 433 439
25. J.L. Francis, A. Drexler, G. Gwyn Successful use of bivalirudin in the treatment of patients suspected, or at risk of, heparin-induced thrombocytopenia Blood 103 2004 4077 (abstr)
26. J.L. Francis, R. Sandhu, A. Drexler Comparison of clinical outcomes in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibitors Blood 103 2004 3942 (abstr)